ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

STJ ST. Jude Medical, Inc.

80.82
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
ST. Jude Medical, Inc. NYSE:STJ NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 80.82 0 01:00:00

St. Jude Medical to Present at the 2015 Credit Suisse Healthcare Conference

30/10/2015 1:10pm

Business Wire


SJM (NYSE:STJ)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more SJM Charts.

St. Jude Medical, Inc. (NYSE:STJ) will present at the 2015 Credit Suisse Healthcare Conference on Tuesday, Nov. 10, in Scottsdale, Ariz. Michael T. Rousseau, chief operating officer, and Eric S. Fain, group president, will address the conference at 10:30 a.m. MST.

A live webcast of the presentation will also be available on the St. Jude Medical Investor Relations website: investors.sjm.com.

About St. Jude Medical

St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases. The company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical has four major clinical focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit sjm.com or follow us on Twitter, @StJudeMedicalIR.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company’s control and the risk factors and other cautionary statements described in the Company’s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company’s Annual Report on Form 10-K for the fiscal year ended January 3, 2015 and Quarterly Report on Form 10-Q for the fiscal quarter ended July 4, 2015. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.

St. Jude Medical, Inc.J.C. Weigelt, 651-756-4347Investor Relationsjweigelt@sjm.com

1 Year SJM Chart

1 Year SJM Chart

1 Month SJM Chart

1 Month SJM Chart

Your Recent History

Delayed Upgrade Clock